MovDisordV3, PascalFrancis, Corpus, bibRecord, 002401

Treatment of essential blepharospasm with quetiapine

Identifieur interne : 002401 ( PascalFrancis/Corpus ); précédent : 002400; suivant : 002402

Treatment of essential blepharospasm with quetiapine

Auteurs : Roy R. Reeves ; Vincent Liberto

Source :

Movement disorders [ 0885-3185 ] ; 2003.

RBID : Pascal:04-0052652

Descripteurs français

Pascal (Inist)
- Blépharospasme, Essentiel, Réfractaire, Quétiapine, Chimiothérapie, Dystonie, Etude cas, Traitement, Pronostic, Personne âgée, Mâle.

English descriptors

KwdEn :
- Blepharospasm, Case study, Chemotherapy, Dystonia, Elderly, Essential, Male, Prognosis, Quetiapine, Refractory, Treatment.

Abstract

A 69-year-old male with blepharospasm unresponsive to several medications who was successfully treated with quetiapine is described. His symptoms were largely alleviated by low doses, but he experienced sedation, which permitted him to take the medication at bedtime only.

Notice en format standard (ISO 2709)

Pour connaître la documentation sur le format Inist Standard.

A01	`01`	`1`		`@0 0885-3185`
A03		`1`		`@0 Mov. disord.`
A05				`@2 18`
A06				`@2 9`
A08	`01`	`1`	`ENG`	`@1 Treatment of essential blepharospasm with quetiapine`
A11	`01`	`1`		`@1 REEVES (Roy R.)`
A11	`02`	`1`		`@1 LIBERTO (Vincent)`
A14	`01`			`@1 University of Mississippi School of Medicine, and G. V. (Sonny) Montgomery VA Medical Center @2 Jackson, Mississippi @3 USA @Z 1 aut. @Z 2 aut.`
A20				`@1 1072-1073`
A21				`@1 2003`
A23	`01`			`@0 ENG`
A43	`01`			`@1 INIST @2 20953 @5 354000113072050210`
A44				`@0 0000 @1 © 2004 INIST-CNRS. All rights reserved.`
A45				`@0 11 ref.`
A47	`01`	`1`		`@0 04-0052652`
A60				`@1 P`
A61				`@0 A`
A64	`01`	`1`		`@0 Movement disorders`
A66	`01`			`@0 USA`
C01	`01`		`ENG`	`@0 A 69-year-old male with blepharospasm unresponsive to several medications who was successfully treated with quetiapine is described. His symptoms were largely alleviated by low doses, but he experienced sedation, which permitted him to take the medication at bedtime only.`
C02	`01`	`X`		`@0 002B02B11`
C03	`01`	`X`	`FRE`	`@0 Blépharospasme @5 01`
C03	`01`	`X`	`ENG`	`@0 Blepharospasm @5 01`
C03	`01`	`X`	`SPA`	`@0 Blefaroespasmo @5 01`
C03	`02`	`X`	`FRE`	`@0 Essentiel @5 02`
C03	`02`	`X`	`ENG`	`@0 Essential @5 02`
C03	`02`	`X`	`SPA`	`@0 Esencial @5 02`
C03	`03`	`X`	`FRE`	`@0 Réfractaire @5 03`
C03	`03`	`X`	`ENG`	`@0 Refractory @5 03`
C03	`03`	`X`	`SPA`	`@0 Refractario @5 03`
C03	`04`	`X`	`FRE`	`@0 Quétiapine @2 NK @2 FR @5 04`
C03	`04`	`X`	`ENG`	`@0 Quetiapine @2 NK @2 FR @5 04`
C03	`04`	`X`	`SPA`	`@0 Quetiapina @2 NK @2 FR @5 04`
C03	`05`	`X`	`FRE`	`@0 Chimiothérapie @5 05`
C03	`05`	`X`	`ENG`	`@0 Chemotherapy @5 05`
C03	`05`	`X`	`SPA`	`@0 Quimioterapia @5 05`
C03	`06`	`X`	`FRE`	`@0 Dystonie @5 07`
C03	`06`	`X`	`ENG`	`@0 Dystonia @5 07`
C03	`06`	`X`	`SPA`	`@0 Distonía @5 07`
C03	`07`	`X`	`FRE`	`@0 Etude cas @5 17`
C03	`07`	`X`	`ENG`	`@0 Case study @5 17`
C03	`07`	`X`	`SPA`	`@0 Estudio caso @5 17`
C03	`08`	`X`	`FRE`	`@0 Traitement @5 18`
C03	`08`	`X`	`ENG`	`@0 Treatment @5 18`
C03	`08`	`X`	`SPA`	`@0 Tratamiento @5 18`
C03	`09`	`X`	`FRE`	`@0 Pronostic @5 19`
C03	`09`	`X`	`ENG`	`@0 Prognosis @5 19`
C03	`09`	`X`	`SPA`	`@0 Pronóstico @5 19`
C03	`10`	`X`	`FRE`	`@0 Personne âgée @5 20`
C03	`10`	`X`	`ENG`	`@0 Elderly @5 20`
C03	`10`	`X`	`SPA`	`@0 Anciano @5 20`
C03	`11`	`X`	`FRE`	`@0 Mâle @5 21`
C03	`11`	`X`	`ENG`	`@0 Male @5 21`
C03	`11`	`X`	`SPA`	`@0 Macho @5 21`
C07	`01`	`X`	`FRE`	`@0 Homme`
C07	`01`	`X`	`ENG`	`@0 Human`
C07	`01`	`X`	`SPA`	`@0 Hombre`
C07	`02`	`X`	`FRE`	`@0 Oeil pathologie @5 37`
C07	`02`	`X`	`ENG`	`@0 Eye disease @5 37`
C07	`02`	`X`	`SPA`	`@0 Ojo patología @5 37`
C07	`03`	`X`	`FRE`	`@0 Paupière pathologie @5 38`
C07	`03`	`X`	`ENG`	`@0 Eyelid disease @5 38`
C07	`03`	`X`	`SPA`	`@0 Párpado patología @5 38`
C07	`04`	`X`	`FRE`	`@0 Neuroleptique @5 45`
C07	`04`	`X`	`ENG`	`@0 Neuroleptic @5 45`
C07	`04`	`X`	`SPA`	`@0 Neuroléptico @5 45`
C07	`05`	`X`	`FRE`	`@0 Psychotrope @2 FX @5 46`
C07	`05`	`X`	`ENG`	`@0 Psychotropic @2 FX @5 46`
C07	`05`	`X`	`SPA`	`@0 Psicotropo @2 FX @5 46`
C07	`06`	`X`	`FRE`	`@0 Hypnotique @5 47`
C07	`06`	`X`	`ENG`	`@0 Hypnotic @5 47`
C07	`06`	`X`	`SPA`	`@0 Hipnótico @5 47`
C07	`07`	`X`	`FRE`	`@0 Tranquillisant @5 48`
C07	`07`	`X`	`ENG`	`@0 Tranquillizer @5 48`
C07	`07`	`X`	`SPA`	`@0 Tranquilizante @5 48`
C07	`08`	`X`	`FRE`	`@0 Muscle strié pathologie @5 53`
C07	`08`	`X`	`ENG`	`@0 Striated muscle disease @5 53`
C07	`08`	`X`	`SPA`	`@0 Músculo estriado patología @5 53`
C07	`09`	`X`	`FRE`	`@0 Système nerveux pathologie @5 54`
C07	`09`	`X`	`ENG`	`@0 Nervous system diseases @5 54`
C07	`09`	`X`	`SPA`	`@0 Sistema nervioso patología @5 54`
C07	`10`	`X`	`FRE`	`@0 Trouble neurologique @5 55`
C07	`10`	`X`	`ENG`	`@0 Neurological disorder @5 55`
C07	`10`	`X`	`SPA`	`@0 Trastorno neurológico @5 55`
C07	`11`	`X`	`FRE`	`@0 Mouvement involontaire @5 56`
C07	`11`	`X`	`ENG`	`@0 Involuntary movement @5 56`
C07	`11`	`X`	`SPA`	`@0 Movimiento involuntario @5 56`
C07	`12`	`X`	`FRE`	`@0 Extrapyramidal syndrome @5 57`
C07	`12`	`X`	`ENG`	`@0 Extrapyramidal syndrome @5 57`
C07	`12`	`X`	`SPA`	`@0 Extrapiramidal síndrome @5 57`
N21				`@1 033`
N82				`@1 PSI`

Format Inist (serveur)

NO :	PASCAL 04-0052652 INIST
ET :	Treatment of essential blepharospasm with quetiapine
AU :	REEVES (Roy R.); LIBERTO (Vincent)
AF :	University of Mississippi School of Medicine, and G. V. (Sonny) Montgomery VA Medical Center/Jackson, Mississippi/Etats-Unis (1 aut., 2 aut.)
DT :	Publication en série; Niveau analytique
SO :	Movement disorders; ISSN 0885-3185; Etats-Unis; Da. 2003; Vol. 18; No. 9; Pp. 1072-1073; Bibl. 11 ref.
LA :	Anglais
EA :	A 69-year-old male with blepharospasm unresponsive to several medications who was successfully treated with quetiapine is described. His symptoms were largely alleviated by low doses, but he experienced sedation, which permitted him to take the medication at bedtime only.
CC :	002B02B11
FD :	Blépharospasme; Essentiel; Réfractaire; Quétiapine; Chimiothérapie; Dystonie; Etude cas; Traitement; Pronostic; Personne âgée; Mâle
FG :	Homme; Oeil pathologie; Paupière pathologie; Neuroleptique; Psychotrope; Hypnotique; Tranquillisant; Muscle strié pathologie; Système nerveux pathologie; Trouble neurologique; Mouvement involontaire; Extrapyramidal syndrome
ED :	Blepharospasm; Essential; Refractory; Quetiapine; Chemotherapy; Dystonia; Case study; Treatment; Prognosis; Elderly; Male
EG :	Human; Eye disease; Eyelid disease; Neuroleptic; Psychotropic; Hypnotic; Tranquillizer; Striated muscle disease; Nervous system diseases; Neurological disorder; Involuntary movement; Extrapyramidal syndrome
SD :	Blefaroespasmo; Esencial; Refractario; Quetiapina; Quimioterapia; Distonía; Estudio caso; Tratamiento; Pronóstico; Anciano; Macho
LO :	INIST-20953.354000113072050210
ID :	04-0052652

Links to Exploration step

Pascal:04-0052652

Le document en format XML

<record><TEI><teiHeader><fileDesc><titleStmt><title xml:lang="en" level="a">Treatment of essential blepharospasm with quetiapine</title>
<author><name sortKey="Reeves, Roy R" sort="Reeves, Roy R" uniqKey="Reeves R" first="Roy R." last="Reeves">Roy R. Reeves</name>
<affiliation><inist:fA14 i1="01"><s1>University of Mississippi School of Medicine, and G. V. (Sonny) Montgomery VA Medical Center</s1>
<s2>Jackson, Mississippi</s2>
<s3>USA</s3>
<sZ>1 aut.</sZ>
<sZ>2 aut.</sZ>
</inist:fA14>
</affiliation>
</author>
<author><name sortKey="Liberto, Vincent" sort="Liberto, Vincent" uniqKey="Liberto V" first="Vincent" last="Liberto">Vincent Liberto</name>
<affiliation><inist:fA14 i1="01"><s1>University of Mississippi School of Medicine, and G. V. (Sonny) Montgomery VA Medical Center</s1>
<s2>Jackson, Mississippi</s2>
<s3>USA</s3>
<sZ>1 aut.</sZ>
<sZ>2 aut.</sZ>
</inist:fA14>
</affiliation>
</author>
</titleStmt>
<publicationStmt><idno type="wicri:source">INIST</idno>
<idno type="inist">04-0052652</idno>
<date when="2003">2003</date>
<idno type="stanalyst">PASCAL 04-0052652 INIST</idno>
<idno type="RBID">Pascal:04-0052652</idno>
<idno type="wicri:Area/PascalFrancis/Corpus">002401</idno>
</publicationStmt>
<sourceDesc><biblStruct><analytic><title xml:lang="en" level="a">Treatment of essential blepharospasm with quetiapine</title>
<author><name sortKey="Reeves, Roy R" sort="Reeves, Roy R" uniqKey="Reeves R" first="Roy R." last="Reeves">Roy R. Reeves</name>
<affiliation><inist:fA14 i1="01"><s1>University of Mississippi School of Medicine, and G. V. (Sonny) Montgomery VA Medical Center</s1>
<s2>Jackson, Mississippi</s2>
<s3>USA</s3>
<sZ>1 aut.</sZ>
<sZ>2 aut.</sZ>
</inist:fA14>
</affiliation>
</author>
<author><name sortKey="Liberto, Vincent" sort="Liberto, Vincent" uniqKey="Liberto V" first="Vincent" last="Liberto">Vincent Liberto</name>
<affiliation><inist:fA14 i1="01"><s1>University of Mississippi School of Medicine, and G. V. (Sonny) Montgomery VA Medical Center</s1>
<s2>Jackson, Mississippi</s2>
<s3>USA</s3>
<sZ>1 aut.</sZ>
<sZ>2 aut.</sZ>
</inist:fA14>
</affiliation>
</author>
</analytic>
<series><title level="j" type="main">Movement disorders</title>
<title level="j" type="abbreviated">Mov. disord.</title>
<idno type="ISSN">0885-3185</idno>
<imprint><date when="2003">2003</date>
</imprint>
</series>
</biblStruct>
</sourceDesc>
<seriesStmt><title level="j" type="main">Movement disorders</title>
<title level="j" type="abbreviated">Mov. disord.</title>
<idno type="ISSN">0885-3185</idno>
</seriesStmt>
</fileDesc>
<profileDesc><textClass><keywords scheme="KwdEn" xml:lang="en"><term>Blepharospasm</term>
<term>Case study</term>
<term>Chemotherapy</term>
<term>Dystonia</term>
<term>Elderly</term>
<term>Essential</term>
<term>Male</term>
<term>Prognosis</term>
<term>Quetiapine</term>
<term>Refractory</term>
<term>Treatment</term>
</keywords>
<keywords scheme="Pascal" xml:lang="fr"><term>Blépharospasme</term>
<term>Essentiel</term>
<term>Réfractaire</term>
<term>Quétiapine</term>
<term>Chimiothérapie</term>
<term>Dystonie</term>
<term>Etude cas</term>
<term>Traitement</term>
<term>Pronostic</term>
<term>Personne âgée</term>
<term>Mâle</term>
</keywords>
</textClass>
</profileDesc>
</teiHeader>
<front><div type="abstract" xml:lang="en">A 69-year-old male with blepharospasm unresponsive to several medications who was successfully treated with quetiapine is described. His symptoms were largely alleviated by low doses, but he experienced sedation, which permitted him to take the medication at bedtime only.</div>
</front>
</TEI>
<inist><standard h6="B"><pA><fA01 i1="01" i2="1"><s0>0885-3185</s0>
</fA01>
<fA03 i2="1"><s0>Mov. disord.</s0>
</fA03>
<fA05><s2>18</s2>
</fA05>
<fA06><s2>9</s2>
</fA06>
<fA08 i1="01" i2="1" l="ENG"><s1>Treatment of essential blepharospasm with quetiapine</s1>
</fA08>
<fA11 i1="01" i2="1"><s1>REEVES (Roy R.)</s1>
</fA11>
<fA11 i1="02" i2="1"><s1>LIBERTO (Vincent)</s1>
</fA11>
<fA14 i1="01"><s1>University of Mississippi School of Medicine, and G. V. (Sonny) Montgomery VA Medical Center</s1>
<s2>Jackson, Mississippi</s2>
<s3>USA</s3>
<sZ>1 aut.</sZ>
<sZ>2 aut.</sZ>
</fA14>
<fA20><s1>1072-1073</s1>
</fA20>
<fA21><s1>2003</s1>
</fA21>
<fA23 i1="01"><s0>ENG</s0>
</fA23>
<fA43 i1="01"><s1>INIST</s1>
<s2>20953</s2>
<s5>354000113072050210</s5>
</fA43>
<fA44><s0>0000</s0>
<s1>© 2004 INIST-CNRS. All rights reserved.</s1>
</fA44>
<fA45><s0>11 ref.</s0>
</fA45>
<fA47 i1="01" i2="1"><s0>04-0052652</s0>
</fA47>
<fA60><s1>P</s1>
</fA60>
<fA61><s0>A</s0>
</fA61>
<fA64 i1="01" i2="1"><s0>Movement disorders</s0>
</fA64>
<fA66 i1="01"><s0>USA</s0>
</fA66>
<fC01 i1="01" l="ENG"><s0>A 69-year-old male with blepharospasm unresponsive to several medications who was successfully treated with quetiapine is described. His symptoms were largely alleviated by low doses, but he experienced sedation, which permitted him to take the medication at bedtime only.</s0>
</fC01>
<fC02 i1="01" i2="X"><s0>002B02B11</s0>
</fC02>
<fC03 i1="01" i2="X" l="FRE"><s0>Blépharospasme</s0>
<s5>01</s5>
</fC03>
<fC03 i1="01" i2="X" l="ENG"><s0>Blepharospasm</s0>
<s5>01</s5>
</fC03>
<fC03 i1="01" i2="X" l="SPA"><s0>Blefaroespasmo</s0>
<s5>01</s5>
</fC03>
<fC03 i1="02" i2="X" l="FRE"><s0>Essentiel</s0>
<s5>02</s5>
</fC03>
<fC03 i1="02" i2="X" l="ENG"><s0>Essential</s0>
<s5>02</s5>
</fC03>
<fC03 i1="02" i2="X" l="SPA"><s0>Esencial</s0>
<s5>02</s5>
</fC03>
<fC03 i1="03" i2="X" l="FRE"><s0>Réfractaire</s0>
<s5>03</s5>
</fC03>
<fC03 i1="03" i2="X" l="ENG"><s0>Refractory</s0>
<s5>03</s5>
</fC03>
<fC03 i1="03" i2="X" l="SPA"><s0>Refractario</s0>
<s5>03</s5>
</fC03>
<fC03 i1="04" i2="X" l="FRE"><s0>Quétiapine</s0>
<s2>NK</s2>
<s2>FR</s2>
<s5>04</s5>
</fC03>
<fC03 i1="04" i2="X" l="ENG"><s0>Quetiapine</s0>
<s2>NK</s2>
<s2>FR</s2>
<s5>04</s5>
</fC03>
<fC03 i1="04" i2="X" l="SPA"><s0>Quetiapina</s0>
<s2>NK</s2>
<s2>FR</s2>
<s5>04</s5>
</fC03>
<fC03 i1="05" i2="X" l="FRE"><s0>Chimiothérapie</s0>
<s5>05</s5>
</fC03>
<fC03 i1="05" i2="X" l="ENG"><s0>Chemotherapy</s0>
<s5>05</s5>
</fC03>
<fC03 i1="05" i2="X" l="SPA"><s0>Quimioterapia</s0>
<s5>05</s5>
</fC03>
<fC03 i1="06" i2="X" l="FRE"><s0>Dystonie</s0>
<s5>07</s5>
</fC03>
<fC03 i1="06" i2="X" l="ENG"><s0>Dystonia</s0>
<s5>07</s5>
</fC03>
<fC03 i1="06" i2="X" l="SPA"><s0>Distonía</s0>
<s5>07</s5>
</fC03>
<fC03 i1="07" i2="X" l="FRE"><s0>Etude cas</s0>
<s5>17</s5>
</fC03>
<fC03 i1="07" i2="X" l="ENG"><s0>Case study</s0>
<s5>17</s5>
</fC03>
<fC03 i1="07" i2="X" l="SPA"><s0>Estudio caso</s0>
<s5>17</s5>
</fC03>
<fC03 i1="08" i2="X" l="FRE"><s0>Traitement</s0>
<s5>18</s5>
</fC03>
<fC03 i1="08" i2="X" l="ENG"><s0>Treatment</s0>
<s5>18</s5>
</fC03>
<fC03 i1="08" i2="X" l="SPA"><s0>Tratamiento</s0>
<s5>18</s5>
</fC03>
<fC03 i1="09" i2="X" l="FRE"><s0>Pronostic</s0>
<s5>19</s5>
</fC03>
<fC03 i1="09" i2="X" l="ENG"><s0>Prognosis</s0>
<s5>19</s5>
</fC03>
<fC03 i1="09" i2="X" l="SPA"><s0>Pronóstico</s0>
<s5>19</s5>
</fC03>
<fC03 i1="10" i2="X" l="FRE"><s0>Personne âgée</s0>
<s5>20</s5>
</fC03>
<fC03 i1="10" i2="X" l="ENG"><s0>Elderly</s0>
<s5>20</s5>
</fC03>
<fC03 i1="10" i2="X" l="SPA"><s0>Anciano</s0>
<s5>20</s5>
</fC03>
<fC03 i1="11" i2="X" l="FRE"><s0>Mâle</s0>
<s5>21</s5>
</fC03>
<fC03 i1="11" i2="X" l="ENG"><s0>Male</s0>
<s5>21</s5>
</fC03>
<fC03 i1="11" i2="X" l="SPA"><s0>Macho</s0>
<s5>21</s5>
</fC03>
<fC07 i1="01" i2="X" l="FRE"><s0>Homme</s0>
</fC07>
<fC07 i1="01" i2="X" l="ENG"><s0>Human</s0>
</fC07>
<fC07 i1="01" i2="X" l="SPA"><s0>Hombre</s0>
</fC07>
<fC07 i1="02" i2="X" l="FRE"><s0>Oeil pathologie</s0>
<s5>37</s5>
</fC07>
<fC07 i1="02" i2="X" l="ENG"><s0>Eye disease</s0>
<s5>37</s5>
</fC07>
<fC07 i1="02" i2="X" l="SPA"><s0>Ojo patología</s0>
<s5>37</s5>
</fC07>
<fC07 i1="03" i2="X" l="FRE"><s0>Paupière pathologie</s0>
<s5>38</s5>
</fC07>
<fC07 i1="03" i2="X" l="ENG"><s0>Eyelid disease</s0>
<s5>38</s5>
</fC07>
<fC07 i1="03" i2="X" l="SPA"><s0>Párpado patología</s0>
<s5>38</s5>
</fC07>
<fC07 i1="04" i2="X" l="FRE"><s0>Neuroleptique</s0>
<s5>45</s5>
</fC07>
<fC07 i1="04" i2="X" l="ENG"><s0>Neuroleptic</s0>
<s5>45</s5>
</fC07>
<fC07 i1="04" i2="X" l="SPA"><s0>Neuroléptico</s0>
<s5>45</s5>
</fC07>
<fC07 i1="05" i2="X" l="FRE"><s0>Psychotrope</s0>
<s2>FX</s2>
<s5>46</s5>
</fC07>
<fC07 i1="05" i2="X" l="ENG"><s0>Psychotropic</s0>
<s2>FX</s2>
<s5>46</s5>
</fC07>
<fC07 i1="05" i2="X" l="SPA"><s0>Psicotropo</s0>
<s2>FX</s2>
<s5>46</s5>
</fC07>
<fC07 i1="06" i2="X" l="FRE"><s0>Hypnotique</s0>
<s5>47</s5>
</fC07>
<fC07 i1="06" i2="X" l="ENG"><s0>Hypnotic</s0>
<s5>47</s5>
</fC07>
<fC07 i1="06" i2="X" l="SPA"><s0>Hipnótico</s0>
<s5>47</s5>
</fC07>
<fC07 i1="07" i2="X" l="FRE"><s0>Tranquillisant</s0>
<s5>48</s5>
</fC07>
<fC07 i1="07" i2="X" l="ENG"><s0>Tranquillizer</s0>
<s5>48</s5>
</fC07>
<fC07 i1="07" i2="X" l="SPA"><s0>Tranquilizante</s0>
<s5>48</s5>
</fC07>
<fC07 i1="08" i2="X" l="FRE"><s0>Muscle strié pathologie</s0>
<s5>53</s5>
</fC07>
<fC07 i1="08" i2="X" l="ENG"><s0>Striated muscle disease</s0>
<s5>53</s5>
</fC07>
<fC07 i1="08" i2="X" l="SPA"><s0>Músculo estriado patología</s0>
<s5>53</s5>
</fC07>
<fC07 i1="09" i2="X" l="FRE"><s0>Système nerveux pathologie</s0>
<s5>54</s5>
</fC07>
<fC07 i1="09" i2="X" l="ENG"><s0>Nervous system diseases</s0>
<s5>54</s5>
</fC07>
<fC07 i1="09" i2="X" l="SPA"><s0>Sistema nervioso patología</s0>
<s5>54</s5>
</fC07>
<fC07 i1="10" i2="X" l="FRE"><s0>Trouble neurologique</s0>
<s5>55</s5>
</fC07>
<fC07 i1="10" i2="X" l="ENG"><s0>Neurological disorder</s0>
<s5>55</s5>
</fC07>
<fC07 i1="10" i2="X" l="SPA"><s0>Trastorno neurológico</s0>
<s5>55</s5>
</fC07>
<fC07 i1="11" i2="X" l="FRE"><s0>Mouvement involontaire</s0>
<s5>56</s5>
</fC07>
<fC07 i1="11" i2="X" l="ENG"><s0>Involuntary movement</s0>
<s5>56</s5>
</fC07>
<fC07 i1="11" i2="X" l="SPA"><s0>Movimiento involuntario</s0>
<s5>56</s5>
</fC07>
<fC07 i1="12" i2="X" l="FRE"><s0>Extrapyramidal syndrome</s0>
<s5>57</s5>
</fC07>
<fC07 i1="12" i2="X" l="ENG"><s0>Extrapyramidal syndrome</s0>
<s5>57</s5>
</fC07>
<fC07 i1="12" i2="X" l="SPA"><s0>Extrapiramidal síndrome</s0>
<s5>57</s5>
</fC07>
<fN21><s1>033</s1>
</fN21>
<fN82><s1>PSI</s1>
</fN82>
</pA>
</standard>
<server><NO>PASCAL 04-0052652 INIST</NO>
<ET>Treatment of essential blepharospasm with quetiapine</ET>
<AU>REEVES (Roy R.); LIBERTO (Vincent)</AU>
<AF>University of Mississippi School of Medicine, and G. V. (Sonny) Montgomery VA Medical Center/Jackson, Mississippi/Etats-Unis (1 aut., 2 aut.)</AF>
<DT>Publication en série; Niveau analytique</DT>
<SO>Movement disorders; ISSN 0885-3185; Etats-Unis; Da. 2003; Vol. 18; No. 9; Pp. 1072-1073; Bibl. 11 ref.</SO>
<LA>Anglais</LA>
<EA>A 69-year-old male with blepharospasm unresponsive to several medications who was successfully treated with quetiapine is described. His symptoms were largely alleviated by low doses, but he experienced sedation, which permitted him to take the medication at bedtime only.</EA>
<CC>002B02B11</CC>
<FD>Blépharospasme; Essentiel; Réfractaire; Quétiapine; Chimiothérapie; Dystonie; Etude cas; Traitement; Pronostic; Personne âgée; Mâle</FD>
<FG>Homme; Oeil pathologie; Paupière pathologie; Neuroleptique; Psychotrope; Hypnotique; Tranquillisant; Muscle strié pathologie; Système nerveux pathologie; Trouble neurologique; Mouvement involontaire; Extrapyramidal syndrome</FG>
<ED>Blepharospasm; Essential; Refractory; Quetiapine; Chemotherapy; Dystonia; Case study; Treatment; Prognosis; Elderly; Male</ED>
<EG>Human; Eye disease; Eyelid disease; Neuroleptic; Psychotropic; Hypnotic; Tranquillizer; Striated muscle disease; Nervous system diseases; Neurological disorder; Involuntary movement; Extrapyramidal syndrome</EG>
<SD>Blefaroespasmo; Esencial; Refractario; Quetiapina; Quimioterapia; Distonía; Estudio caso; Tratamiento; Pronóstico; Anciano; Macho</SD>
<LO>INIST-20953.354000113072050210</LO>
<ID>04-0052652</ID>
</server>
</inist>
</record>

Pour manipuler ce document sous Unix (Dilib)

EXPLOR_STEP=$WICRI_ROOT/Wicri/Santé/explor/MovDisordV3/Data/PascalFrancis/Corpus

HfdSelect -h $EXPLOR_STEP/biblio.hfd -nk 002401 | SxmlIndent | more

HfdSelect -h $EXPLOR_AREA/Data/PascalFrancis/Corpus/biblio.hfd -nk 002401 | SxmlIndent | more

Pour mettre un lien sur cette page dans le réseau Wicri

{{Explor lien
   |wiki=    Wicri/Santé
   |area=    MovDisordV3
   |flux=    PascalFrancis
   |étape=   Corpus
   |type=    RBID
   |clé=     Pascal:04-0052652
   |texte=   Treatment of essential blepharospasm with quetiapine
}}

This area was generated with Dilib version V0.6.23.
Data generation: Sun Jul 3 12:29:32 2016. Site generation: Wed Feb 14 10:52:30 2024

	Movement Disorders (revue)
	Attention, ce site est en cours de développement ! Attention, site généré par des moyens informatiques à partir de corpus bruts. Les informations ne sont donc pas validées.

Movement Disorders (revue)

Treatment of essential blepharospasm with quetiapine

Treatment of essential blepharospasm with quetiapine

Source :

Descripteurs français

English descriptors

Abstract

Notice en format standard (ISO 2709)

Format Inist (serveur)

Links to Exploration step

Le document en format XML

Pour manipuler ce document sous Unix (Dilib)

Pour mettre un lien sur cette page dans le réseau Wicri